Menu
Annual · values202520242023202220212020
Operating Cash Flow349.08 M USD222.54 M USD182.31 M USD141.71 M USD175.80 M USD188.06 M USD
Depreciation & Amortization88.57 M USD80.65 M USD78.48 M USD64.82 M USD56.38 M USD54.10 M USD
Stock-Based Compensation
Capital Expenditures-261.90 M USD-299.45 M USD-432.66 M USD-234.88 M USD-106.52 M USD-89.55 M USD
Cash Flow from Investing
Cash Flow from Financing
Dividends Paid
Stock Buybacks
Free Cash Flow11.04 M USD-157.79 M USD-336.72 M USD-139.81 M USD20.16 M USD59.65 M USD

Stevanato Group S.p.A. is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The company offers an integrated portfolio of products, processes, and services that support customers across the entire drug life cycle, from development and clinical stages to commercial production. Its Biopharmaceutical and Diagnostic Solutions segment provides glass primary packaging such as vials, cartridges, syringes, and ampoules, alongside plastic components for drug delivery systems and in-vitro diagnostic consumables. The Engineering segment delivers specialized equipment including visual inspection systems, assembly lines, glass converting machinery, secondary packaging solutions, and analytical services to ensure product quality and regulatory compliance. Stevanato Group S.p.A. emphasizes technological innovation, manufacturing excellence, and a global footprint with production sites in multiple countries. Founded in 1949 and headquartered in Piombino Dese, Padua, Italy, it serves major players in the biopharmaceutical sector with end-to-end solutions for injectable drugs and diagnostic applications.